Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2023 ▲▼ | Q1 2024 ▲▼ | Change ▲▼ | Q4 2023 ▲▼ | Q1 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Newamsterdam Pharma Company ORDINARY SHARES | 10,473,913 | 10,473,913 | 0 | $116.99M | $247.71M | 19.91% | +$130.71M |
| Nuvalent Inc | 3,577,267 | 2,697,267 | -880,000 | $263.25M | $202.54M | 16.28% | -$60.71M |
| Dianthus Therapeutics, Inc.(DNTH) | 0 | 2,992,028 | +2,992,028 | $0 | $89.76M | 7.21% | +$89.76M |
| Disc Medicine, Inc.(IRON) | 1,332,545 | 1,317,213 | -15,332 | $76.97M | $82.01M | 6.59% | +$5.04M |
| Kyverna Therapeutics, Inc.(KYTX) | 0 | 3,163,868 | +3,163,868 | $0 | $78.59M | 6.32% | +$78.59M |
| Pharvaris N V COM | 3,904,319 | 3,303,381 | -600,938 | $109.52M | $76.34M | 6.14% | -$33.18M |
| Savara Inc.(SVRA) | 14,232,751 | 14,565,457 | +332,706 | $66.89M | $72.54M | 5.83% | +$5.64M |
| Annexon, Inc.(ANNX) | 8,061,719 | 8,703,268 | +641,549 | $36.60M | $62.40M | 5.02% | +$25.80M |
| Solid Biosciences Inc | 3,130,422 | 4,034,582 | +904,160 | $19.22M | $53.74M | 4.32% | +$34.52M |
| Madrigal Pharmaceuticals, Inc.(MDGL) | 324,619 | 196,995 | -127,624 | $75.11M | $52.61M | 4.23% | -$22.50M |
| Mersana Therapeutics Inc | 8,663,673 | 8,663,673 | 0 | $20.10M | $38.81M | 3.12% | +$18.71M |
| Cabaletta Bio, Inc.(CABA) | 2,000,000 | 1,617,364 | -382,636 | $45.40M | $27.59M | 2.22% | -$17.81M |
| X4 Pharmaceuticals, Inc.(XFOR) | 16,915,784 | 16,915,784 | 0 | $14.18M | $23.51M | 1.89% | +$9.33M |
| Tango Therapeutics, Inc.(TNGX) | 2,892,663 | 2,892,663 | 0 | $28.64M | $22.97M | 1.85% | -$5.67M |
| Arcutis Biotherapeutics, Inc.(ARQT) | 3,000,000 | 2,011,687 | -988,313 | $9.69M | $19.94M | 1.60% | +$10.25M |
| Nurix Therapeutics, Inc.(NRIX) | 1,822,883 | 1,132,397 | -690,486 | $18.81M | $16.65M | 1.34% | -$2.17M |
| Syros Pharmaceuticals Inc | 2,749,808 | 2,749,808 | 0 | $21.42M | $14.71M | 1.18% | -$6.71M |
| Marinus Pharmaceuticals Inc | 1,431,058 | 1,393,380 | -37,678 | $15.56M | $12.60M | 1.01% | -$2.96M |
| Atea Pharmaceuticals, Inc.(AVIR) | 2,485,638 | 2,485,638 | 0 | $7.58M | $10.04M | 0.81% | +$2.46M |
| C4 Therapeutics, Inc.(CCCC) | 1,642,210 | 1,142,210 | -500,000 | $9.28M | $9.33M | 0.75% | +$53.4K |
| Rapid Micro Biosystems, Inc.CL A(RPID) | 8,434,560 | 8,434,560 | 0 | $6.24M | $8.18M | 0.66% | +$1.94M |
| Invivyd, Inc.(IVVD) | 1,937,207 | 1,799,595 | -137,612 | $7.63M | $7.99M | 0.64% | +$357.6K |
| Nautilus Biotechnology, Inc.(NAUT) | 2,000,000 | 2,000,000 | 0 | $5.98M | $5.88M | 0.47% | -$100.0K |
| Aclaris Therapeutics, Inc.(ACRS) | 3,500,000 | 3,000,000 | -500,000 | $3.67M | $3.72M | 0.30% | +$45.0K |
| Xilio Therapeutics, Inc.(XLO) | 2,805,413 | 2,805,413 | 0 | $1.54M | $3.03M | 0.24% | +$1.49M |
| Newamsterdam Pharma CompanyW EXP 99 99 999 *W EXP 99/99/999 | 100,000 | 100,000 | 0 | $313.0K | $1.10M | 0.09% | +$791.0K |
| 2seventy Bio Inc | 1,331,801 | 0 | -1,331,801 | $5.69M | $0 | — | -$5.69M |
| Natera, Inc.(NTRA) | 400,197 | 0 | -400,197 | $25.07M | $0 | — | -$25.07M |
| Revolution Medicines, Inc.(RVMD) | 1,112,396 | 0 | -1,112,396 | $31.90M | $0 | — | -$31.90M |